TD Asset Management Portfolio holdings
AUM
$117B
1-Year Return
25.17%
This Quarter Return
+11%
1 Year Return
+25.17%
3 Year Return
+87.06%
5 Year Return
+156.45%
10 Year Return
+305.53%
AUM
$107B
AUM Growth
+$5.79B
(+5.7%)
Cap. Flow
-$2.63B
Cap. Flow
% of AUM
-2.44%
Top 10 Holdings %
Top 10 Hldgs %
24.55%
Holding
1,462
New
74
Increased
672
Reduced
527
Closed
81
Top Buys
| 1 |
AbbVie
ABBV
|
+$386M |
| 2 |
Procter & Gamble
PG
|
+$310M |
| 3 |
Meta Platforms (Facebook)
META
|
+$292M |
| 4 |
CRH
CRH
|
+$276M |
| 5 |
Republic Services
RSG
|
+$267M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
Apple
AAPL
|
+$780M |
| 3 |
UnitedHealth
UNH
|
+$465M |
| 4 |
Microsoft
MSFT
|
+$445M |
| 5 |
NVIDIA
NVDA
|
+$433M |
Sector Composition
| 1 | Technology | 20.15% |
| 2 | Financials | 19.67% |
| 3 | Healthcare | 11.58% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Rockwell Automation
ROK
$38.2B
| $11.8M | 0.01% |
40,392
+48
| +0.1% | +$14K |
|
|
XYZ
602
Block, Inc.
XYZ
$45B
| $11.7M | 0.01% |
138,220
+3,131
| +2% | +$265K |
|
603
Xcel Energy
XEL
$42.8B
| $11.6M | 0.01% |
216,158
+1,368
| +0.6% | +$73.5K |
|
604
Insmed
INSM
$30.8B
| $11.6M | 0.01% |
427,178
-36,354
| -8% | -$986K |
|
605
CRISPR Therapeutics
CRSP
$4.71B
| $11.4M | 0.01% |
166,794
-59,068
| -26% | -$4.03M |
|
606
Confluent
CFLT
$6.9B
| $11.3M | 0.01% |
368,950
-33,986
| -8% | -$1.04M |
|
607
Illumina
ILMN
$14.7B
| $11.2M | 0.01% |
84,172
-23,592
| -22% | -$3.15M |
|
608
Best Buy
BBY
$16.1B
| $11M | 0.01% |
134,249
+7,226
| +6% | +$593K |
|
609
Crinetics Pharmaceuticals
CRNX
$3.3B
| $11M | 0.01% |
235,198
+58,772
| +33% | +$2.75M |
|
610
Jones Lang LaSalle
JLL
$14.6B
| $10.9M | 0.01% |
55,967
-800
| -1% | -$156K |
|
611
Xylem
XYL
$33.5B
| $10.9M | 0.01% |
84,006
+1,186
| +1% | +$153K |
|
612
T Rowe Price
TROW
$23.4B
| $10.8M | 0.01% |
88,665
+3,253
| +4% | +$397K |
|
613
Amcor
AMCR
$19B
| $10.7M | 0.01% |
1,123,729
+477,722
| +74% | +$4.54M |
|
614
Repligen
RGEN
$6.76B
| $10.6M | 0.01% |
57,732
-3,900
| -6% | -$717K |
|
615
Snowflake
SNOW
$76.5B
| $10.6M | 0.01% |
65,558
-113
| -0.2% | -$18.3K |
|
616
Ciena
CIEN
$18.4B
| $10.5M | 0.01% |
+212,000
| New | +$10.5M |
|
617
Legend Biotech
LEGN
$6.18B
| $10.5M | 0.01% |
186,392
-51,824
| -22% | -$2.91M |
|
618
Roblox
RBLX
$92.1B
| $10.3M | 0.01% |
270,842
+164,161
| +154% | +$6.27M |
|
619
Flowserve
FLS
$7.35B
| $10.3M | 0.01% |
225,710
-3,151
| -1% | -$144K |
|
620
Ultragenyx Pharmaceutical
RARE
$3.02B
| $10.3M | 0.01% |
220,360
-1,000
| -0.5% | -$46.7K |
|
621
MoonLake Immunotherapeutics
MLTX
$3.44B
| $10.3M | 0.01% |
204,094
-5,048
| -2% | -$254K |
|
622
Fifth Third Bancorp
FITB
$30.1B
| $10.2M | 0.01% |
273,924
+14,620
| +6% | +$544K |
|
623
Brown-Forman Class B
BF.B
$12.9B
| $10.1M | 0.01% |
195,386
-2,604
| -1% | -$134K |
|
624
Palantir
PLTR
$396B
| $10.1M | 0.01% |
437,843
+11,104
| +3% | +$256K |
|
625
Toast
TOST
$23.3B
| $10.1M | 0.01% |
404,148
+289,000
| +251% | +$7.2M |
|